148
Views
23
CrossRef citations to date
0
Altmetric
Original Research

The ACE2-Ang-(1‑7)-Mas Axis Modulates M1/M2 Macrophage Polarization to Relieve CLP-Induced Inflammation via TLR4-Mediated NF-кb and MAPK Pathways

, , , , , , & show all
Pages 2045-2060 | Published online: 20 May 2021

References

  • Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell. 2010;140:771–776. doi:10.1016/j.cell.2010.03.006
  • Weiss U. Inflammation. Nature. 2008;454:7203. doi:10.1038/454427a
  • Varela ML, Mogildea M, Moreno I, et al. Acute inflammation and metabolism. Inflammation. 2018;41:1115–1127. doi:10.1007/s10753-018-0739-1
  • Faix JD. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013;50:23–36. doi:10.3109/10408363.2013.764490
  • Chazaud B. Inflammation and skeletal muscle regeneration: leave it to the macrophages! Trends Immunol. 2020;41:481–492. doi:10.1016/j.it.2020.04.006
  • Schappe MS, Szteyn K, Stremska ME, et al. Chanzyme TRPM7 mediates the Ca2+ influx essential for lipopolysaccharide-induced toll-like receptor 4 endocytosis and macrophage activation. Immunity. 2018;48:59–74. doi:10.1016/j.immuni.2017.11.026
  • Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122:787–795. doi:10.1172/JCI59643
  • Liu L, Guo H, Song A, et al. Progranulin inhibits LPS-induced macrophage M1 polarization via NF-кB and MAPK pathways. BMC Immunol. 2020;21(1):32–44. doi:10.1186/s12865-020-00355-y
  • Lescoat A, Lelong M, Jeljeli M, et al. Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: perspectives for scleroderma-associated interstitial lung disease. Biochem Pharmacol. 2020;178:114103. doi:10.1016/j.bcp.2020.114103
  • Mills CD, Kincaid K, Alt JM, et al. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 2000;164:6166–6173. doi:10.4049/jimmunol.164.12.6166
  • Liu YC, Zou XB, Chai YF, Yao YM. Macrophage polarization in inflammatory diseases. Int J Biol Sci. 2014;10:520–529. doi:10.7150/ijbs.8879
  • Orecchioni M, Ghosheh Y, Pramod AB, et al. Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages. Front Immunol. 2019;10:1084. doi:10.3389/fimmu.2019.01084
  • Romero CA, Orias M, Weir MR, et al. Novel RAAS agonists and antagonists: clinical applications and controversies. Nat Rev Endocrinol. 2015;11:242–252. doi:10.1038/nrendo.2015.6
  • AlQudah M, Hale TM, Czubryt MP, et al. Targeting the renin-angiotensin-aldosterone system in fibrosis. Matrix Biol. 2020;91-92:92–108. doi:10.1016/j.matbio.2020.04.005
  • Simões e Silva AC, Silveira KD, Ferreira AJ, et al. ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis. Br J Pharmacol. 2013;169:477–492. doi:10.1111/bph.12159
  • Huang W, Tang L, Cai Y, et al. Effect and mechanism of the Ang-(1-7) on human mesangial cells injury induced by low density lipoprotein. Biochem Biophys Res Commun. 2014;450:1051–1057. doi:10.1016/j.bbrc.2014.06.107
  • Jiang M, Huang W, Wang Z, et al. Anti-inflammatory effects of Ang-(1–7) via TLR4-mediated inhibition of the JNK/FoxO1 pathway in lipopolysaccharide-stimulated RAW264.7 cells. Dev Comp Immunol. 2019;92:291–298. doi:10.1016/j.dci.2018.11.009
  • Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233:6425–6440. doi:10.1002/jcp.26429
  • Liu L, Zhu X, Zhao T, et al. Sirt1 ameliorates monosodium urate crystal-induced inflammation by altering macrophage polarization via the PI3K/Akt/STAT6 pathway. Rheumatology. 2019;58:1674–1683. doi:10.1093/rheumatology/kez165
  • Yunna C, Mengru H, Lei W, et al. Macrophage M1/M2 polarization. Eur J Pharmacol. 2020;877:173090. doi:10.1016/j.ejphar.2020.173090
  • Broderick L, De Nardo D, Franklin BS, et al. The inflammasomes and autoinflammatory syndromes. Annu Rev Pathol. 2015;10:395–424. doi:10.1146/annurev-pathol-012414-040431
  • Tartey S, Kanneganti T. Inflammasomes in the pathophysiology of autoinflammatory syndromes. J Leukoc Biol. 2020;107:379–391. doi:10.1002/JLB.3MIR0919-191R
  • O’Hare FM, Watson RW, Molloy EJ. Toll-like receptors in neonatal sepsis. Acta Pædiatrica. 2013;102:572–578. doi:10.1111/apa.12201
  • e Silva ACS, Teixeira MM. ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis. Pharmacol Res. 2016;107:154–162. doi:10.1016/j.phrs.2016.03.018
  • Rodrigues Prestes TR, Rocha NP, Miranda AS, et al. The anti-inflammatory potential of ACE2/angiotensin-(1-7)/Mas receptor axis: evidence from basic and clinical research. Curr Drug Targets. 2017;18:1301–1313. doi:10.2174/1389450117666160727142401
  • Souza L, Duchene J, Todiras M, et al. Receptor MAS protects mice against hypothermia and mortality induced by endotoxemia. Shock. 2014;41:331–336. doi:10.1097/SHK.0000000000000115